A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen

被引:64
作者
Steegborn, C
Litvin, TN
Hess, KC
Capper, AB
Taussig, R
Buck, J
Levin, LR
Wu, H
机构
[1] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA
[3] Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA
关键词
D O I
10.1074/jbc.M507144200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Catechol estrogens are steroid metabolites that elicit physiological responses through binding to a variety of cellular targets. We show here that catechol estrogens directly inhibit soluble adenylyl cyclases and the abundant trans-membrane adenylyl cyclases. Catechol estrogen inhibition is non-competitive with respect to the substrate ATP, and we solved the crystal structure of a catechol estrogen bound to a soluble adenylyl cyclase from Spirulina platensis in complex with a substrate analog. The catechol estrogen is bound to a newly identified, conserved hydrophobic patch near the active center but distinct from the ATP-binding cleft. Inhibitor binding leads to a chelating interaction between the catechol estrogen hydroxyl groups and the catalytic magnesium ion, distorting the active site and trapping the enzyme substrate complex in a non-productive conformation. This novel inhibition mechanism likely applies to other adenylyl cyclase inhibitors, and the identified ligand-binding site has important implications for the development of specific adenylyl cyclase inhibitors.
引用
收藏
页码:31754 / 31759
页数:6
相关论文
共 48 条
[1]   Catechol estrogens as inhibitors of leukotriene synthesis [J].
Alanko, J ;
Sievi, E ;
Lahteenmaki, T ;
Mucha, I ;
Vapaatalo, H ;
Parantainen, J .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (01) :101-104
[2]   Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury [J].
Bertini, R ;
Allegretti, M ;
Bizzarri, C ;
Moriconi, A ;
Locati, M ;
Zampella, G ;
Cervellera, MN ;
Di Cioccio, V ;
Cesta, MC ;
Galliera, E ;
Martinez, FO ;
Di Bitondo, R ;
Troiani, G ;
Sabbatini, V ;
D'Anniballe, G ;
Anacardio, R ;
Cutrin, JC ;
Cavalieri, B ;
Mainiero, F ;
Strippoli, R ;
Villa, P ;
Di Girolamo, M ;
Martin, F ;
Gentile, M ;
Santoni, A ;
Corda, D ;
Poli, G ;
Mantovani, A ;
Ghezzi, P ;
Colotta, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) :11791-11796
[3]   Structural analysis of adenylate cyclases from Trypanosoma brucei in their monomeric state [J].
Bieger, B ;
Essen, LO .
EMBO JOURNAL, 2001, 20 (03) :433-445
[4]  
BRAUN T, 1990, P SOC EXP BIOL MED, V194, P58
[5]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[6]   Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals [J].
Buck, J ;
Sinclair, ML ;
Schapal, L ;
Cann, MJ ;
Levin, LR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :79-84
[7]  
Buck J, 2002, METHOD ENZYMOL, V345, P95
[8]   Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor [J].
Chen, YQ ;
Cann, MJ ;
Litvin, TN ;
Iourgenko, V ;
Sinclair, ML ;
Levin, LR ;
Buck, J .
SCIENCE, 2000, 289 (5479) :625-628
[9]   Estrogenic responses in estrogen receptor-alpha deficient mice reveal a distinct estrogen signaling pathway [J].
Das, SK ;
Taylor, JA ;
Korach, KS ;
Paria, BC ;
Dey, SK ;
Lubahn, DB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :12786-12791
[10]   The interactions of adenylate cyclases with P-site inhibitors [J].
Dessauer, CW ;
Tesmer, JJG ;
Sprang, SR ;
Gilman, AG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (05) :205-210